Mobile System Captures and Manages ECG Data
By HospiMedica International staff writers Posted on 24 Jun 2015 |
Image: The InvisionHeart 12-lead ECG device (Photo courtesy of InvisionHeart).
A novel cloud-based healthcare IT platform enables physicians, nurses, and care providers to capture, review, and annotate patient 12-lead electrocardiogram (ECG) tracings.
The InvisionHeart ECG System is a mobile, cost-effective, technological solution for capturing and managing 12-lead ECGs, including the ability to read and visually compare, confirm, report, and store diagnostic quality readings. A proprietary high resolution 12-lead ECG device with an intuitive capture system is first used to record the ECG. The data is then transmitted to InvisionConnect, a secure cloud-based platform that allows a network of physicians, nurses, and technicians, to securely access and interpret patient the ECG readings.
Credentialed users can access ECGs from any web-enabled device, and additional cloud-based tools, such as messaging and notifications, help in the timely evaluation of patient ECGs. A web-based application with enhanced diagnostic tools assists in the review and formal diagnosis of patient ECGs, and integrates with electronic medical record systems (EMRs). The InvisionHeart ECG System is a product of InvisionHeart (Nashville, TN, USA), and has been approved by the US Food and Drug Administration (FDA).
“Initial interest has been strong from a broad array of potential users, especially those challenged to find a high-quality, low-cost solution that is secure and fully electronic,” said Melanie Varin, executive vice president of sales and marketing at InvisionHeart. “In addition to hospitals, we’ve detected genuine enthusiasm from the rapidly growing markets for home health and ambulatory care as well as other specialty markets.”
“This is a significant milestone in the development of our technology and, more importantly, a breakthrough in our ability to serve patients where ECGs have been traditionally unavailable,” said Josh Nickols, PhD, President and CEO of InvisionHeart. “Earlier diagnosis of cardiac issues via improved access will benefit patients, whether in the hospital setting or at home.”
In a conventional 12-lead ECG, electrodes are placed on the patient's limbs and on the surface of the chest. The overall magnitude of the heart's electrical potential is then measured from twelve different angles and is recorded over a period of time (usually 10 seconds). The heart's electrical depolarization is thus captured at each moment throughout the cardiac cycle, displayed as a graph representing of voltage versus time, i.e., the ECG.
Related Links:
InvisionHeart
The InvisionHeart ECG System is a mobile, cost-effective, technological solution for capturing and managing 12-lead ECGs, including the ability to read and visually compare, confirm, report, and store diagnostic quality readings. A proprietary high resolution 12-lead ECG device with an intuitive capture system is first used to record the ECG. The data is then transmitted to InvisionConnect, a secure cloud-based platform that allows a network of physicians, nurses, and technicians, to securely access and interpret patient the ECG readings.
Credentialed users can access ECGs from any web-enabled device, and additional cloud-based tools, such as messaging and notifications, help in the timely evaluation of patient ECGs. A web-based application with enhanced diagnostic tools assists in the review and formal diagnosis of patient ECGs, and integrates with electronic medical record systems (EMRs). The InvisionHeart ECG System is a product of InvisionHeart (Nashville, TN, USA), and has been approved by the US Food and Drug Administration (FDA).
“Initial interest has been strong from a broad array of potential users, especially those challenged to find a high-quality, low-cost solution that is secure and fully electronic,” said Melanie Varin, executive vice president of sales and marketing at InvisionHeart. “In addition to hospitals, we’ve detected genuine enthusiasm from the rapidly growing markets for home health and ambulatory care as well as other specialty markets.”
“This is a significant milestone in the development of our technology and, more importantly, a breakthrough in our ability to serve patients where ECGs have been traditionally unavailable,” said Josh Nickols, PhD, President and CEO of InvisionHeart. “Earlier diagnosis of cardiac issues via improved access will benefit patients, whether in the hospital setting or at home.”
In a conventional 12-lead ECG, electrodes are placed on the patient's limbs and on the surface of the chest. The overall magnitude of the heart's electrical potential is then measured from twelve different angles and is recorded over a period of time (usually 10 seconds). The heart's electrical depolarization is thus captured at each moment throughout the cardiac cycle, displayed as a graph representing of voltage versus time, i.e., the ECG.
Related Links:
InvisionHeart
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure